| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA5276519
Max Phase: Preclinical
Molecular Formula: C15H8N4O2
Molecular Weight: 276.25
Associated Items:
Representations
Canonical SMILES: N#Cc1nc2c(nc1C#N)C1(OCCO1)c1ccccc1-2
Standard InChI: InChI=1S/C15H8N4O2/c16-7-11-12(8-17)19-14-13(18-11)9-3-1-2-4-10(9)15(14)20-5-6-21-15/h1-4H,5-6H2
Standard InChI Key: SRDZVQATVIGJSQ-UHFFFAOYSA-N
Associated Targets(Human)
USP7 Tchem Ubiquitin carboxyl-terminal hydrolase 7 (837 Activities)
USP47 Tchem Ubiquitin carboxyl-terminal hydrolase 47 (99 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
USP8 Tchem Ubiquitin carboxyl-terminal hydrolase 8 (245 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 276.25 | Molecular Weight (Monoisotopic): 276.0647 | AlogP: 1.45 | #Rotatable Bonds: 0 |
| Polar Surface Area: 91.82 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 0 |
| #RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: | CX Basic pKa: | CX LogP: 2.41 | CX LogD: 2.41 |
| Aromatic Rings: 2 | Heavy Atoms: 21 | QED Weighted: 0.72 | Np Likeness Score: -0.38 |
References
| 1. Li P, Liu HM.. (2020) Recent advances in the development of ubiquitin-specific-processing protease 7 (USP7) inhibitors., 191 [PMID:32092586] [10.1016/j.ejmech.2020.112107] |
Source
Source(1):